Double maintains 3 strategies that include GKOS - Glaukos Corp.
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| TAIL | -55.79% | $94.86M | 0.59% |
| VIXY | -50.57% | $184.73M | 0.85% |
| BTAL | -50.48% | $315.93M | 1.43% |
| IVOL | -30.36% | $342.69M | 1.02% |
| SPTS | -27.17% | $5.77B | 0.03% |
| SCHO | -24.68% | $10.98B | 0.03% |
| FXY | -24.25% | $802.69M | 0.4% |
| VGSH | -23.68% | $22.68B | 0.03% |
| XONE | -22.60% | $628.85M | 0.03% |
| UTWO | -22.26% | $376.33M | 0.15% |
| IBTI | -21.89% | $1.06B | 0.07% |
| IEI | -21.66% | $15.53B | 0.15% |
| IBTJ | -21.30% | $686.15M | 0.07% |
| IBTK | -21.14% | $445.94M | 0.07% |
| BWX | -21.05% | $1.53B | 0.35% |
| FTSD | -20.82% | $233.11M | 0.25% |
| TPMN | -20.70% | $31.06M | 0.65% |
| IBTG | -20.40% | $1.92B | 0.07% |
| IBTL | -20.29% | $381.26M | 0.07% |
| VGIT | -20.06% | $31.63B | 0.04% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| NUAG | 0.01% | $58.25M | 0.19% |
| SCHJ | -0.02% | $530.19M | 0.03% |
| IBDT | -0.20% | $2.85B | 0.1% |
| BSCR | 0.24% | $3.71B | 0.1% |
| SPSB | -0.32% | $8.09B | 0.04% |
| TBIL | -0.35% | $5.76B | 0.15% |
| JSI | 0.39% | $878.22M | 0.49% |
| PYLD | -0.47% | $6.03B | 0.69% |
| GSY | -0.47% | $2.73B | 0.22% |
| DFCF | -0.53% | $7.10B | 0.17% |
| YEAR | -0.63% | $1.46B | 0.25% |
| CANE | -0.75% | $11.14M | 0.29% |
| FXC | 0.77% | $92.85M | 0.4% |
| IBDZ | -0.82% | $363.32M | 0.1% |
| IBMP | -0.86% | $553.56M | 0.18% |
| MUB | -0.89% | $38.59B | 0.05% |
| WIP | -1.02% | $379.44M | 0.5% |
| FEMB | -1.12% | $209.10M | 0.85% |
| MINO | 1.20% | $318.78M | 0.39% |
| KCCA | -1.20% | $108.37M | 0.87% |
Current Value
$104.981 Year Return
Current Value
$104.981 Year Return
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| HOOD | 62.27% | $87.10B | +347.82% | 0.00% |
| SYF | 60.90% | $27.08B | +45.01% | 1.49% |
| TRMB | 59.89% | $19.28B | +43.70% | 0.00% |
| EVR | 59.49% | $11.56B | +32.60% | 1.09% |
| AIT | 59.41% | $9.75B | +33.86% | 0.66% |
| GS | 58.69% | $217.59B | +47.97% | 1.70% |
| OWL | 58.66% | $12.26B | +12.26% | 3.95% |
| CG | 58.23% | $21.13B | +37.32% | 2.43% |
| EQH | 58.08% | $16.34B | +27.88% | 1.85% |
| KKR | 57.69% | $127.41B | +31.42% | 0.50% |
| PH | 57.49% | $91.27B | +35.24% | 0.94% |
| WCC | 57.27% | $9.82B | +21.62% | 0.87% |
| COF | 57.04% | $141.30B | +58.82% | 1.09% |
| CCL | 56.99% | $38.19B | +60.60% | 0.00% |
| SOFI | 56.80% | $23.18B | +209.75% | 0.00% |
| ITT | 56.76% | $12.40B | +19.14% | 0.86% |
| STEP | 56.69% | $4.62B | +30.18% | 1.61% |
| IBKR | 56.59% | $25.68B | +94.70% | 1.81% |
| MS | 56.56% | $229.56B | +36.74% | 2.60% |
| TPG | 56.43% | $7.73B | +31.90% | 3.13% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| NGG | 0.09% | $69.26B | +12.41% | 4.39% |
| CELH | 0.10% | $11.65B | -22.80% | 0.00% |
| KDP | 0.19% | $45.70B | +3.76% | 2.75% |
| MOH | -0.27% | $12.39B | -21.20% | 0.00% |
| UUU | -0.27% | $8.22M | +134.65% | 0.00% |
| KHC | 0.28% | $31.33B | -17.74% | 6.12% |
| VOD | -0.32% | $26.61B | +18.72% | 4.50% |
| IMNN | -0.32% | $13.21M | -54.55% | 0.00% |
| BF.A | -0.36% | $13.83B | -33.80% | 3.11% |
| VSA | -0.39% | $8.59M | -17.17% | 0.00% |
| REYN | -0.40% | $4.61B | -18.40% | 4.20% |
| SOHU | 0.43% | $417.01M | -10.23% | 0.00% |
| STG | 0.65% | $38.79M | -3.01% | 0.00% |
| BTI | 0.69% | $111.18B | +57.68% | 6.01% |
| CLX | 0.72% | $15.76B | -5.19% | 3.83% |
| SJM | -0.72% | $11.17B | -5.83% | 4.17% |
| PPL | 0.76% | $25.38B | +21.65% | 3.11% |
| GFI | -0.78% | $21.43B | +47.60% | 2.33% |
| MCK | 0.79% | $89.25B | +24.22% | 0.40% |
| TAK | 0.81% | $46.71B | +10.75% | 4.49% |
Yahoo
GKOS posts record Q1 on iDose TR strength, but reimbursement hurdles and legacy declines may hurt its near-term outlook.
Yahoo
ALISO VIEJO, Calif., July 09, 2025--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release second quarter 2025 financial results after the market close on Wednesday, July 30, 2025. The company’s management will discuss the results during a conference call and simultaneous webcast at 1:30 p.m. PT (4:30 p.m. ET) on July 30, 2025.
Yahoo
FUKUOKA, Japan & NEW YORK, July 08, 2025--FELIQS Corporation ("FELIQS"), a biotechnology company developing first-in-class small molecule therapeutics targeting oxidized lipids for rare pediatric retinal diseases, today announced the today announced the appointment of two distinguished industry leaders, Gregory Kunst and Joe Zenkus, to its Board of Directors. The appointments follow a recently secured investment aimed at accelerating FELIQS’s clinical programs.
Finnhub
Glaukos Corporation added to Russell 2000 Growth-Defensive Index...
Finnhub
Glaukos Corporation added to Russell 2000 Defensive Index...
Yahoo
The iStent infinite Trabecular Micro-Bypass System Model iS3 is for minimising IOP in those with primary open-angle glaucoma.
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| FNY | 65.96% | $389.03M | 0.7% |
| PFUT | 65.69% | $362.77M | 0.65% |
| VBK | 65.60% | $19.19B | 0.07% |
| IWO | 65.41% | $11.77B | 0.24% |
| ARKF | 65.40% | $1.21B | 0.75% |
| ARKK | 65.15% | $6.81B | 0.75% |
| VXF | 65.09% | $22.53B | 0.05% |
| IWP | 64.83% | $19.43B | 0.23% |
| RDTE | 64.38% | $139.04M | 0.97% |
| FXL | 64.17% | $1.38B | 0.62% |
| BUZZ | 64.14% | $69.55M | 0.76% |
| ISCG | 63.91% | $688.57M | 0.06% |
| IMCG | 63.78% | $2.82B | 0.06% |
| QQQJ | 63.57% | $625.39M | 0.15% |
| QGRO | 63.55% | $1.75B | 0.29% |
| XSW | 63.55% | $509.81M | 0.35% |
| VOT | 63.47% | $17.34B | 0.07% |
| FPX | 63.45% | $959.22M | 0.61% |
| SCHM | 63.36% | $11.77B | 0.04% |
| ESML | 63.22% | $1.88B | 0.17% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CBOE | -26.62% | $24.55B | +38.09% | 1.08% |
| ED | -25.10% | $36.42B | +10.51% | 3.36% |
| AWK | -21.98% | $27.82B | +4.74% | 2.18% |
| TEF | -21.65% | $29.35B | +18.72% | 6.32% |
| MKTX | -16.50% | $8.21B | +2.36% | 1.37% |
| AEP | -15.69% | $56.65B | +16.73% | 3.49% |
| CME | -15.32% | $99.17B | +44.04% | 1.75% |
| HSY | -14.72% | $33.36B | -11.86% | 3.35% |
| MDLZ | -14.69% | $86.95B | +2.80% | 2.82% |
| DUK | -14.61% | $91.85B | +13.12% | 3.57% |
| GIS | -14.49% | $27.86B | -18.70% | 5.88% |
| MO | -14.36% | $98.62B | +24.36% | 7.00% |
| WTRG | -14.12% | $10.52B | -6.15% | 3.49% |
| KO | -13.79% | $300.31B | +10.57% | 2.87% |
| MSEX | -13.69% | $997.80M | -1.54% | 2.41% |
| CL | -13.41% | $73.44B | -7.30% | 2.25% |
| NOC | -13.10% | $73.96B | +18.95% | 1.66% |
| AMT | -13.09% | $103.46B | +6.67% | 3.01% |
| EXC | -12.57% | $44.05B | +23.53% | 3.60% |
| TU | -12.23% | $25.21B | +7.34% | 6.98% |
